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 The presence of a proinfl ammatory milieu in the airway is important for the development of a range 
of infl ammatory lung diseases. Adequate assessment 
of infl ammatory cells, cytokines, chemokines, and 
antiinfl ammatory molecules is essential for under-
standing, monitoring, and treating these disorders. 
Induced sputum provides a noninvasive means of 
investigating airways infl ammation. 1 Induced sputum 
has a fl uid phase containing a heterogeneous mix 
of proteins and nonorganic substances. A number of 
cytokines, including interleukin (IL)-8, have been 
measured, 2 albeit with signifi cant interstudy variation 
in reported levels. 3 The nonorganic component, how-
ever, has been largely neglected. 
 Previous work performed by this group has demon-
strated high levels of the neutrophil protein calprotectin 
in the sputum 4 and lavage fl uid 5 of patients with CF 
and non-CF bronchiectasis. Calprotectin possesses anti-
microbial properties mediated by the chelation of zinc. 6,7 
It has been demonstrated recently that calprotectin is 
recruited to staphylococcal abscesses in a neutrophil-
dependent manner and inhibits  Staphylococcus 
 Background:  Induced sputum cytology and protein biomarkers can be used to assess airways 
infl ammation. Increases in sputum iron have been described in infl ammatory lung disease. We 
hypothesized that other sputum metals may be affected by airways infl ammation and investigated 
their potential value as biomarkers. 
 Methods:  Sputum was obtained from 20 healthy control subjects and from patients with infl am-
matory pulmonary diseases (23 with cystic fi brosis [CF], 16 with bronchiectasis, 17 with asthma, 
and 23 with COPD), and iron, zinc, manganese, and copper were measured. Fourteen patients 
with CF were also studied through an exacerbation cycle. 
 Results:  Sputum zinc and iron were elevated in CF and non-CF bronchiectasis vs controls ( P  , .001, 
zinc;  P  , .01 iron). Manganese was elevated in asthma ( P  , .01) and bronchiectasis ( P  , .05) vs 
controls. Copper was elevated in CF vs controls ( P  , .05). Zinc decreased ( P  , .01) following treat-
ment of CF exacerbation. In subjects with CF zinc levels correlated with other biomarkers. 
 Conclusions:  These results suggest a relationship of high concentrations of total zinc and iron 
with airways infl ammation in CF and non-CF bronchiectasis, with longitudinal changes being 
observed in CF. Further work is required to elucidate potential infl ammatory mechanisms 
related to these observations.  CHEST 2010; 137(3):635–641 
 Abbreviations:  CF  5 cystic fi brosis; IL  5 interleukin; MPO  5 myeloperoxidase; PBS  5 phosphate-buffered saline; 
SOD  5 superoxide dismutase 
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 Sputum Induction 
 Sputum induction was performed by a standard method as pre-
viously described. 15-17 In brief, patients inhaled nebulized hyper-
tonic saline at concentrations of 3%, 4%, and 5% and were asked 
to expectorate after each inhalation until a sample was obtained. 
Patients with CF underwent induction unless freely expectorating 
in keeping with previous CF sputum studies. 18,19 Nine of 23 subjects 
with CF spontaneously produced sputum without induction. 
 Sputum Processing 
 Sputum was processed within 2 hours of collection as described 
previously. 15 In brief, sputum plugs were harvested and processed 
with 4  3 weight/volume of 0.1% dithiothreitol in phosphate-buffered 
saline (PBS), after which 4  3 weight/volume of PBS was added. 
Samples were fi ltered through 48- m m mesh and centrifuged at 
1,200 rpm to remove the cells. Supernatant was stored at  2 80°C 
until further analysis without protease inhibitor. The cell pellet was 
resuspended in PBS and used for cytospin preparation. Cytospins 
were stained with May-Grunwald-Giemsa for differential cell count-
ing. All cell counts were expressed as percentage of the population 
counted. Total cell count was not performed prior to cytospin. All 
samples used in this study contained , 40% squamous cells. 
 Trace Element Assay 
 Trace element assay was performed in the Scottish National Trace 
Element Reference Laboratory, Glasgow, Scotland. A four-point 
calibration was used (0, 100, 500, 1,000  m g/L copper, iron, zinc, man-
ganese in 1% nitric acid). Sputum samples were centrifuged at 800 g 
for 5 min and 200  m L of sample was then diluted with 2 mL internal 
standard solution (100  m /L yttrium in 1% nitric acid) and mixed by 
inversion. Internal accuracy was assessed by use of two aqueous certi-
fi ed reference  materials, TMDA62 and TMDA64 (Prochem; Chess-
ington, England). Trace element levels were measured by inductively 
coupled plasma optical emission spectrometry using a VISTA AX 
(Varian; Oxford, England). 
 Measurement of Sputum IL-8, Myeloperoxidase, 
and Calprotectin 
 To compare the results of metals in sputum with biochemical 
markers of infl ammation, comparisons with IL-8, myeloperoxidase 
(MPO), and calprotectin were made in the CF group. Immunoas-
says used commercially available sandwich enzyme-linked immu-
nosorbent assay kits, following the manufacturer’s instructions. The 
kits used were IL-8 (Biosource Europe SA; Nivelles, Belgium ), 
MPO (Assay Designs Inc; Ann Arbor, MI), and Calprotectin 
(Buhlmann Laboratories, AG; Schonenbuch, Switzerland ). 
 Data Analysis 
 Data analysis was carried out on GraphPad Prism software 
(GraphPad; La Jolla, CA ) for Windows. Cross-sectional data were 
nonnormally distributed and were analyzed by Kruskal-Wallis 
analysis of variance and Dunn multiple comparison test.  P  , .05 
was considered signifi cant. For longitudinal analysis of zinc and 
iron data a paired Student  t test was performed. For correlation, 
data were subjected to Spearman rank analysis. 
 Results 
 Subject Demographics 
 The demographic profi les and sputum cytology of 
each group are shown in  Table 1 . The CF group was 
aureus growth through the chelation of zinc and 
manganese. 8 
 Increased levels of total iron and iron-binding pro-
teins have been reported in the sputum of patients 
with cystic fi brosis (CF) and COPD. 9-12 Scavenging of 
free iron is an important component of antimicrobial 
defense mechanisms against organisms such as 
 Pseudomonas aeruginosa , 13 an important pathogen in 
chronic lung disease. Although iron is clearly an impor-
tant inorganic substance in the airway, other metals, 
such as zinc, may also be important; for example, 
increased zinc levels alter the sensitivity of  Pseudomonas , 
an organism particularly relevant to CF lung  disease, 
to antibiotics. 14 Therefore the measurement of trace 
elements in sputum may allow mechanistic insight 
into diseases such as CF. Furthermore, trace elements, 
likely to be less susceptible to protease  activity, may 
allow more reliable measurement of  infl ammation 
in the airway. Thus we feel that measurement of trace 
elements may allow a more robust sputum measure-
ment of airways disease as well as giving further insight 
into lung infl ammation in diseases such as CF. 
 Based on our previous fi ndings of increased levels of 
calprotectin, a known chelator of zinc, in the airway 
and previous observations related to iron in the CF 
airway we hypothesized that trace metal concentra-
tions, in particular zinc and iron, would be elevated in 
CF and non-CF bronchiectasis compared with control 
populations. We also hypothesized that levels of trace 
element would change following disease intervention 
in CF. Total concentrations of zinc, iron, copper, and 
manganese were measured in subjects with CF, bron-
chiectasis, COPD, and asthma, and in normal controls. 
Furthermore, concentrations of trace elements were 
compared with previously described markers of 
infl ammation in CF, including calprotectin. 
 Materials and Methods 
 Subjects 
 Induced sputum was obtained from patients attending the 
 Respiratory Unit at the Western General Hospital, Edinburgh. 
Approval was obtained from the local regional ethics committee. 
Twenty-three patients with CF, 16 with non-CF bronchiectasis, 17 
with asthma, 23 with COPD, and 20 healthy controls were studied. 
In order to monitor the effects of a changing state of  infl ammation, 
sputum samples were obtained from 14 additional patients with CF 
during CF exacerbation. Exacerbation samples were taken within 
24 hours of starting antibiotic therapy and at the end of treatment. 
 Reagents Used 
 All reagents were purchased from Sigma (Sigma; Gillingham, 
UK ) unless otherwise stated. Ultrapure, high-performance liquid 
chromatography-grade water was used for all experiments and 
preparations. Aristar nitric acid was used in the trace element 
assay. 
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signifi cant effect on the zinc or iron levels in the 
COPD group ( Fig 1 ). 
 Sputum manganese differentiated non-CF bron-
chiectasis but not CF from control ( P  , .05). Sputum 
manganese also differentiated subjects with asthma 
from control subjects ( P  , .01). Sputum copper was 
higher in all disease groups vs control but only 
reached statistical signifi cance for CF ( P  , .01). 
 In some subjects trace element levels were below 
the limit of detection of the assay, in particular for 
manganese. Interestingly, zinc and iron were detect-
able in all subjects with CF. Please refer to  Table 2 
for further information. 
 Correlation of Sputum Zinc and Iron Levels 
With Lung Function, Sputum Cytology, and 
Sputum Biomarkers in Patients With CF 
 As the most statistically signifi cant changes were 
seen in the CF group, further comparisons were 
made with clinical data and other infl ammatory mark-
ers for this group. Sputum zinc and iron levels were 
correlated in patients with CF (Spearman  r 5 0.75, 
 P  , .05, data not shown). There was a negative cor-
relation of zinc and FEV 1 % predicted in the CF 
group (Spearman r 5  2 0.469,  P  , .05,  Fig 2 A ). Spu-
tum iron was also negatively correlated with FEV 1 % 
(Spearman r 5  2 0.43,  P  , .05, data not shown). Spu-
tum neutrophil % and zinc levels were correlated 
(Spearman r 5 0.67,  P  , .05, data not shown). Zinc 
younger than the control and other disease groups 
( P  , .01). Of the COPD group 10 were current  smokers, 
nine ex-smokers, and four gave no information on 
current smoking status. Of the patients with CF, 14 
were colonized with  P aeruginosa , the other patients 
being colonized by a variety of organisms, including 
 Stenotrophomonas maltophilia and  Burkholderia 
cenocepacia species. 
 Assay Reproducibility 
 Pooled samples of fi ve subjects in each group of 
control, CF, and non-CF bronchiectasis were assayed 
in two separate runs for zinc levels with co effi cients 
of variance of 14.7%, 2.7%, and 5.4%, respectively, 
giving an average coeffi cient of variation of 7.6%. 
 Sputum Trace Element Levels in 
Cross-Sectional Data 
 The absolute concentrations of zinc, iron, and man-
ganese are displayed in  Table 2 in  m g/L. Sputum zinc 
concentration was at least fourfold higher in CF and 
non-CF bronchiectasis than controls ( P  , .001). Con-
centrations in CF and non-CF bronchiectasis were 
also higher than in asthma and COPD ( P  , .05). 
 Sputum iron was at least twofold higher in CF and 
non-CF bronchiectasis than controls ( P  , .01) and 
COPD ( P  , .05). Levels were higher in the COPD 
and asthma groups vs controls but did not reach sta-
tistical signifi cance. Current smoking status had no 
 Table 1— Demographics and Sputum Cytology for Subjects in Cross-Sectional and Longitudinal Studies 
Disease No. Male, No. Age, y FEV 1 % Predicted Neutrophil, % Eosinophil, %
Controls 20 6 36.9 (2.5) 105.8 (2.6) 55 (4.3) 2.9 (0.5)
Asthma 17 5 51.9 (3.3) 80 (5.6) 60 (6.1) 16.2 (5.2)
COPD 23 16 66.0 (1.4) 55.0 (4.0) 81 (2.6) 4.4 (1.6)
CF 23 14 26.3 (2.0) 59.1 (4.4) 92 (2.0) 2.4 (0.5)
Bronchiectasis 16 1 62.3 (2.1) 70.4 (8.5) 84 (4.0) 2.1 (1.3)
CF exacerbation 14 8 25.6 (2.4) 41.0 (4.4) 98.3 (0.6) n/d
CF recovery 14 8 25.6 (2.4) 46.3 (4.5) 96.4 (0.9) n/d
Data are displayed as mean (SEM). CF  5 cystic fi brosis; n/d  5 not done.
 Table 2— Levels of Metal Elements ( m g/L) of Processed Sputum Supernatant for Zinc, Iron, Manganese, and Copper 
Disease Zinc Iron Manganese Copper
Control 15.35 (10.4-25.6) 13.5 (8.6-21.5) 0 (0-0.25) 8.6 (3-16.4)
Asthma 12.7 (7.2-41.4) 30.0 (6.9-35.3) 0.8 (0.2-1.7) a 15.2 (8.6-29.5)
COPD 25.4 (9.8-50.7) 21.3 (3.1-35.6) 0 (0-0.7) 15.2 (12.2-22)
CF 135.3 (54.2-209.6) b 56.9 (24.3-115.3) a 0.3 (0.1-0.8) 19.5 (14.5-30.1) c 
Bronchiectasis 111.3 (46.1-150.7) b 54.2 (22.7-91.6) a 0.6 (0.2-1.3) c 15.7 (10.9-33.3)
Data are displayed as: median (interquartile range).  P values are displayed for disease group vs control; for  P values between groups please consult 
text. Zinc was below the limit of detection of the assay in four control and one COPD. Iron was below the limit of detection in four control, one 
asthma, and one COPD. Manganese was below the limit of detection in 14 control, three asthma, 13 COPD, six CF, and one bronchiectasis. See 
Table 1 for expansion of abbreviation.
 a P  , .01 vs control.
 b P  , .001 vs control.
 c P  , .05 vs control.
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subjects. There is a small degree of overlap between 
the CF and control groups, but this may be explained 
by the fi nding that patients with CF in this small sub-
group had better lung function and thus less severe 
lung disease (data not shown). Sputum zinc levels 
were also signifi cantly higher in CF and non-CF 
bronchiectasis compared with COPD. Sputum zinc 
levels decrease signifi cantly over the course of a CF 
exacerbation. Zinc is strongly correlated with calpro-
tectin in CF sputum as well as with other infl amma-
tory markers, such as IL-8 and MPO. 
 Protein biomarkers, such as cytokines, have been 
used in previous studies to assess levels of airways 
infl ammation. 20-22 However, protease activity in expec-
torated sputum may affect the robustness of cytokine 
assays. 23 The potential association we have shown 
 between trace element levels and infl ammation in 
sputum samples combined with their likely resistance 
to degradation commends them as potentially robust 
markers of lung pathophysiology. 
 Serum zinc has previously been suggested as a 
marker of lung disease, 24,25 but we believe this to be 
the fi rst study to describe an association between 
sputum zinc and infl ammation in individuals with CF 
lung disease and non-CF bronchiectasis. Further-
more, we demonstrate its potential use as a serial 
marker during treatment of an exacerbation, although 
this must be interpreted with caution as in two sub-
jects zinc levels actually increased, whereas in four 
others there was only a modest decrease of levels. 
Nevertheless, the majority of subjects demonstrated 
a decrease with treatment and as such further inves-
tigation is clearly merited. 
 We thus suggest that sputum zinc may be used as a 
biomarker in suppurative diseases, such as CF. We 
do realize, however, that as we have used a relatively 
small sample size, albeit similar to those use in previ-
ous biomarker studies, these data represent a novel 
observation and further validation in larger studies is 
required. Furthermore, a parallel measure of zinc in 
serum may have added further insight into the func-
tional signifi cance of these fi ndings, as would knowl-
edge of individual subject dietary zinc intake. 
 Zinc homeostasis may play an important role in 
modulating the immune response to infl ammation, 
with high concentrations of zinc inducing peripheral 
blood monocyte apoptosis 26 and promoting cytokine 
production. 27 Conversely, low concentrations of zinc 
may suppress monocyte function and decrease neu-
trophil phagocytosis. 28 Zinc may also interact with the 
airway epithelium. 29,30 For example, zinc deprivation 
of bronchial epithelial cells in culture induces 
apoptosis, 31,32 and zinc defi ciency in a murine model 
of asthma induces epithelial cell apoptosis and air-
ways infl ammation. 33 We have measured total zinc 
content of sputum (ie, bound and unbound), whereas 
levels were unrelated to the underlying colonizing 
organism (data not shown). 
 Sputum zinc and calprotectin levels correlated 
with high statistical signifi cance (Spearman r  5 0.86, 
 P  , .001,  Fig 2 B ). Sputum zinc signifi cantly correlated 
with MPO and IL-8 (Spearman r  5 0.81,  P  , .001, 
Spearman r  5 0.67,  P  , .001, respectively,  Figures 2 C 
and 2 D ). Sputum iron demonstrated similar but less 
signifi cant correlations to calprotectin, MPO, and 
IL-8 (data not shown). 
 Serial Measurement of Metals in CF Exacerbation 
 Sputum zinc levels decreased signifi cantly follow-
ing antibiotic therapy for an exacerbation ( P  , .01; 
 Fig 3 ). There were no signifi cant serial changes in 
iron, manganese or copper. 
 Discussion 
 Total elemental zinc and iron concentrations are 
elevated in sputum from subjects with CF and non-
CF bronchiectasis compared with healthy control 
 Figure 1. Smoking status and sputum trace element level in 
COPD. Data for zinc ( A ). Data for iron ( B ). 
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prerequisite for microbial growth, with increased levels 
in CF sputum possibly contributing to the proliferation 
of bacteria such as  P aeruginosa . 11 The source of this 
iron is unclear, with leak from the circulation being 
suggested, although further work is required to investi-
gate this. Cigarette smoke has also been suggested as a 
potential source of airways iron, 35 but we have demon-
strated no difference in sputum iron between current 
smokers and ex-smokers with COPD in this study. 
 Associations between the levels of sputum manga-
nese and copper with disease type are less obvious. 
Manganese was only signifi cantly elevated in the 
asthma and non-CF bronchiectasis groups and copper 
only in CF. Both metals (like zinc) are cofactors for 
superoxide dismutases (SODs) , which have leading 
roles in alleviating oxidative stress in the lung. 36 Fur-
thermore, the demonstration that manganese differ-
entiated subjects with asthma from control subjects 
but not subjects with CF from control subjects sug-
gests a possible role for this element in nonsuppurative 
lung disease. SODs are downregulated in asthmatic 
airways, 36 suggesting sputum copper and manganese 
are not merely tracking levels of these mediators. 
A measurement of SOD level or activity would help to 
elucidate this complicated relationship but was not 
performed in this study and thus forms the basis of 
future work by this group. 
 Sputum zinc levels correlated with biomarkers 
of airways infl ammation, namely calprotectin, MPO, 
the amount of freely available unbound zinc might be 
equally important. The excess of zinc in sputum is, 
however, a possible explanation for the low serum 
zinc levels in subjects with CF compared with healthy 
controls. 34 
 Increases in sputum iron have been described in CF 9-12 
and exceed the levels observed in COPD. 12 Iron is a 
 Figure 2. Correlation of sputum zinc with biomarkers of lung infl ammation and physiology. Correlation 
between FEV 1 % predicted and sputum zinc (Spearman r  5   2 0.47,  P  , .05) ( A ). Correlation between 
sputum calprotectin and zinc. (Spearman r  5 0.86,  P  , .001) ( B ). Correlation between sputum MPO and 
zinc (Spearman r  5 0.81,  P  , .001) ( C ). Correlation between sputum IL-8 and zinc (Spearman r  5 0.67, 
 P  , .001) ( D ). IL  5 interleukin; MPO  5 myeloperoxidase. 
 Figure 3. Sputum zinc levels in CF exacerbation (n  5 14). Spu-
tum zinc decreases over the course of an exacerbation with antibi-
otic treatment ( P  , .01). Horizontal lines represent means. 
CF  5 cystic fi brosis. 
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 Iron defi ciency in cystic fi brosis: relationship to lung disease 
and IL-8. Sputum zinc adds to the growing number 
of potential biomarkers in sputum and may be seen 
to compliment these as well as offering new insight 
into pulmonary infl ammation. Calprotectin is a highly 
abundant neutrophil protein found in the CF airway 4,5 
with antiinfl ammatory and proinfl ammatory func-
tions, and the ability to chelate zinc and other 
cations. 7,8,37,38 Calprotectin promotes apoptosis in cell 
lines via the exclusion of zinc, 39,40 and zinc and calpro-
tectin have been demonstrated to colocalize in staph-
ylococcal abscess in a murine model. 8 As such, we 
would suggest that the interaction of zinc and calpro-
tectin in the CF airway is of mechanistic importance, 
particularly when we consider that  S aureus is a major 
pathogen in early disease. 
 Elevated levels of calprotectin and zinc may refl ect 
passive release of the neutrophil contents in view of 
the large number of necrotic neutrophils in the CF 
airway, 41 or may represent active secretion as is 
observed with lactoferrin release from neutrophils. 42 
A passive release of zinc, on cell necrosis, would be sup-
ported by the correlation of zinc with both neutrophil 
percentage in samples and calprotectin, a cytoplas-
mic protein in neutrophils. A more controlled active 
release of zinc may be suggested, however, by the 
correlation of zinc with MPO, a neutrophil granule 
protein released from activated neutrophils. Neverthe-
less, the higher correlation is of zinc, and calprotectin 
might simply refl ect an overall abundance of neutro-
phils, which are rich in both of these substances, 43,44 
as neutrophils contain 5 to 10 ng zinc per 10 6 cells. 43 
It is also important to consider that the zinc we have 
measured in the airway could also be complexed 
to calprotectin (or other proteins) or could be due 
to leakage from the pulmonary circulation during 
infl ammation. 
 In conclusion, we have demonstrated elevated levels 
of trace metals (zinc in particular) in the fl uid phase 
of sputum from patients with CF and non-CF bron-
chiectasis compared with patients with asthma or 
COPD and healthy adult controls. We also demon-
strate that the level of zinc in CF sputum decreases 
over the course of an infective exacerbation and the 
use of chemically stable markers in noninvasive 
assays to monitor the course and severity of lung dis-
eases such as CF would clearly be advantageous. Of 
course a valid biomarker must be highly reproducible 
and repeatable and, as such, longitudinal studies to 
evaluate the robustness of sputum trace metal assays 
of infl ammation are required. 
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